Prior to joining Francisco Partners in 2008, Chris was with American Securities Capital Partners where he evaluated and executed private equity transactions across business services and industrial technology. Chris previously was a strategy consultant in the Atlanta, Sao Paulo, and Sydney offices of Bain & Company. He has also worked at a venture capital firm in Bangalore and a technology startup in Shanghai.
Chris currently serves on the board of directors of CoverMyMeds, GoodRX, Landmark Health, Quantros, and Therapeutic Research Center. He formerly served on the board of directors of Aesynt (acquired by Omnicell), NexTraq (acquired by Fleetcor), QuadraMed (acquired by Nuance and Constellation Software), and was also involved with FP’s investments in Mincom (acquired by ABB), and Hypercom (acquired by Verifone).